NPA1 inhibitors are a class of chemical compounds that specifically target and inhibit the activity of the NPA1 protein. This protein, often found in cellular membranes, is implicated in various biochemical pathways related to cellular transport and structural organization. NPA1 is involved in regulating key processes such as molecular trafficking and intracellular signaling. The inhibition of NPA1 can interfere with its role in maintaining cellular homeostasis, potentially affecting the function and balance of other proteins and molecules in its network. The structural composition of NPA1 inhibitors often consists of heterocyclic or aromatic ring systems, which are designed to interact with the active or allosteric sites of the NPA1 protein, leading to conformational changes that disrupt its function.
At the molecular level, these inhibitors are characterized by their specific binding affinity to NPA1, which is often achieved through hydrogen bonding, hydrophobic interactions, or electrostatic forces. These interactions depend on the inhibitor's chemical structure, which is fine-tuned to optimize binding and maximize inhibition. NPA1 inhibitors are typically explored for their ability to modulate protein-protein interactions and to act as precise molecular tools in studying the function of NPA1 in various biological systems. Research into these inhibitors focuses on understanding their binding kinetics, selectivity, and structural dynamics, contributing to a deeper understanding of how NPA1 regulates cellular processes. This research helps clarify the structural and chemical principles underlying protein inhibition, providing insights into the mechanisms by which small molecules can effectively interfere with protein function.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Interferes with the transcription initiation process by binding to DNA, thereby leading to the downregulation of NPA1 through transcriptional repression. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
Incorporates into RNA in place of uracil, causing errors in RNA processing and ultimately reducing the levels of NPA1 mRNA available for translation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Blocks the mTOR signaling pathway, which is crucial for ribosomal protein synthesis, resulting in a decrease in NPA1 expression as part of a broader inhibition of ribosome biogenesis. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Forms DNA adducts that hinder transcriptional enzymes, leading to a decrease in the transcription of genes including NPA1, by blocking the advancement of RNA polymerase. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
Inhibits RNA polymerase II activity, leading to a specific decrease in transcription of mRNA-encoding genes such as NPA1. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Forms crosslinks within DNA, disrupting the transcription process and potentially leading to decreased expression of NPA1 due to impaired transcription factor binding. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Inhibits the transcription of a wide array of genes by targeting RNA polymerase II, which could result in a specific reduction of NPA1 expression. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
Specifically inhibits RNA polymerase II, leading to a targeted decrease in mRNA synthesis, thereby reducing NPA1 expression at the transcriptional level. | ||||||
Cordycepin | 73-03-0 | sc-203902 | 10 mg | $101.00 | 5 | |
Terminates mRNA chain elongation prematurely, reducing the overall production of NPA1 by limiting the availability of mature mRNA transcripts. | ||||||
Leptomycin B | 87081-35-4 | sc-358688 sc-358688A sc-358688B | 50 µg 500 µg 2.5 mg | $107.00 $416.00 $1248.00 | 35 | |
Inhibits the nuclear export of mRNA by binding to exportin 1, leading to decreased translation of NPA1 mRNA due to its accumulation in the nucleus. | ||||||